Latin America Antimicrobial Susceptibility Testing Market (2024-2029)
The Latin America Antimicrobial Susceptibility Testing Market was valued at $345.1 Million in 2024 and projected to reach to $451.5 Million by 2029, representing a compound annual growth rate of 5.5%. Latin America's Antimicrobial Susceptibility Testing market is poised for sustained growth driven by escalating antimicrobial resistance concerns and healthcare modernization initiatives across the region.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Latin America Antimicrobial Susceptibility Testing Market Trends and Insights
- Latin America's healthcare infrastructure modernization and rising antimicrobial resistance concerns are driving adoption of advanced diagnostic testing solutions across the region.
- In Latin America, increasing investment in clinical laboratory capabilities and regulatory emphasis on infection control are accelerating market penetration. Latin America's AST market growth is supported by expanding hospital networks, growing awareness of antibiotic stewardship programs, and improved access to diagnostic technologies in emerging economies.
- The region's healthcare providers in Latin America are increasingly recognizing the critical role of rapid and accurate susceptibility testing in optimizing treatment outcomes and reducing healthcare costs.
- Between 2024 and 2029, Latin America is expected to see enhanced adoption driven by both public health initiatives and private sector investments in diagnostic infrastructure..
Key Market Statistics
- CAGR (2024-2029) 5.5% CAGR
- Market Size, 2024 ~USD 345.1 Million
- Forecast, 2029 ~USD 451.5 Million
- Geography Latin America
Latin America Antimicrobial Susceptibility Testing Market Overview
Regional Market Valuation :
Latin America's AST market is valued at $345.1 million in 2024, with Brazil and Mexico representing the largest market segments, accounting for over 83% of regional demand.
Rising Antimicrobial Resistance Crisis :
Latin America faces escalating AMR challenges, prompting healthcare institutions to adopt advanced susceptibility testing to combat resistant pathogens and improve patient outcomes across the region.
Healthcare Infrastructure Investment :
Modernization of diagnostic laboratories and increased government funding for healthcare infrastructure in major Latin American economies are accelerating AST technology adoption and market penetration.
Steady Growth Trajectory :
The region is projected to reach $451.5 million by 2029, representing a 5.5% CAGR, outpacing the global average of 5% and reflecting strong regional demand for diagnostic solutions.
Latin America Antimicrobial Susceptibility Testing Market Dynamics
- Brazil and Mexico are leading market drivers, with expanding diagnostic laboratory networks and increased adoption of automated AST platforms.
- Government healthcare reforms and rising awareness of infection control protocols are creating favorable conditions for market expansion. The forecast period through 2029 anticipates continued investment in diagnostic infrastructure, particularly in emerging markets within the region.
- Partnerships between international diagnostic manufacturers and local healthcare providers are expected to enhance market accessibility.
- Additionally, growing prevalence of hospital-acquired infections and regulatory emphasis on antimicrobial stewardship programs will further propel demand for advanced susceptibility testing solutions across Latin American healthcare systems..
Related Ecosystem
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Latin America's AST market is valued at $345.1 million in 2024 and will reach $451.5 million by 2029, representing a 5.5% CAGR.
- Rising antimicrobial resistance and antibiotic stewardship initiatives are primary growth catalysts for Latin America's diagnostic testing market.
- Latin America's expanding hospital infrastructure and improved laboratory investment are accelerating AST technology adoption across the region.
- Latin America's emerging economies present significant growth opportunities as healthcare systems modernize diagnostic capabilities through 2029.
Antimicrobial Susceptibility Testing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | LAB INSTRUMENTS (Product) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 5% from 2024 to 2029 |
| Largest Segment | QUALITATIVE METHODS (Method) |
| Market Size Base Year (Billions) | ~USD 4.45 (2024) |
| Revenue Forecast (Billions) | ~USD 5.68 (2029) |
| Segments Covered | Product, Type, Method, Application, End User |
Latin America Antimicrobial Susceptibility Testing Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Lab Disposables
- Lab Instruments
By Type
- Agar Dilution
- Antibacterial Susceptibility Testing
- Antifungal Susceptibility Testing
- Antiparasitic Susceptibility Testing
- Antiviral Susceptibility Testing
- Automated Ast
- Automated Laboratory Instruments
- Broth Macrodilution
- Culture & Growth Media
- Culture And Growth Media
- Disk Diffusion
- Etest Method
- Genotypic Method
- Mic Strips
- Molecular Diagnostics Systems
- Susceptibility Plates
- Susceptibility Testing Disks
By Method
- Qualitative Methods
- Quantitative Methods
By Application
- Clinical Diagnostics
- Drug Discovery & Development
- Epidemiology
- Other Applications
By End User
- Academic & Research Institutes
- Cros
- Hospitals & Diagnostic Centers
- Pharmaceutical & Biotechnology Companies
Target Audience
- Diagnostic Equipment Manufacturers : Manufacturers need Latin America-specific market data to develop region-appropriate AST platforms, establish distribution networks, and capitalize on the growing demand for automated diagnostic solutions.
- Healthcare System Administrators : Hospital and laboratory administrators require market insights to justify capital investments in AST infrastructure, benchmark against regional peers, and optimize antimicrobial stewardship programs.
- In Vitro Diagnostics (IVD) Companies : IVD manufacturers need detailed Latin America market segmentation to identify growth opportunities, assess competitive positioning, and develop targeted go-to-market strategies for the region.
- Healthcare Investors & Consultants : Investment firms and management consultants require comprehensive regional market analysis to evaluate healthcare diagnostics opportunities, assess portfolio companies, and guide strategic acquisitions.
- Regulatory & Policy Bodies : Government health agencies and regulatory organizations need market intelligence to inform antimicrobial stewardship policies, laboratory standards, and healthcare infrastructure development initiatives.
Countries within Latin America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Brazil | USD 208.7 Million |
| Mexico | USD 152.6 Million |
| Rest Of Latin America | USD 90.1 Million |
Country market size visualization
Reasons to Buy this Report
- Country-Level Market Breakdown : Access detailed market sizing for Brazil ($208.7M) and Mexico ($152.6M), plus Rest of Latin America ($90.1M), enabling precise market targeting and resource allocation strategies.
- Regional Growth Forecasting : Leverage 5-year projections through 2029 to plan product launches, distribution partnerships, and market entry strategies aligned with Latin America's 5.5% CAGR expansion trajectory.
- Competitive Landscape Intelligence : Understand market dynamics specific to Latin America's healthcare infrastructure, regulatory environment, and key players driving AST adoption across major regional markets.
- Antimicrobial Resistance Insights : Gain actionable intelligence on AMR prevalence patterns and healthcare system responses across Latin America to inform product development and clinical positioning strategies.
- Investment Decision Support : Make informed capital allocation decisions with comprehensive market data, growth forecasts, and regional opportunity assessments for Latin American healthcare diagnostics expansion.
Frequently asked questions
What is the current size of the AST market in Latin America?
The Antimicrobial Susceptibility Testing market in Latin America was valued at $345.1 million in 2024.
What is the projected market size for Latin America's AST market by 2029?
Latin America's AST market is forecasted to reach $451.5 million by 2029, growing at a 5.5% CAGR.
What factors are driving growth in Latin America's AST market?
Key drivers in Latin America include rising antimicrobial resistance, expanding hospital networks, antibiotic stewardship programs, and increased laboratory infrastructure investment.
How does Latin America's AST market growth compare to global trends?
Latin America's 5.5% CAGR slightly exceeds the global average of 5%, reflecting strong regional healthcare modernization efforts.
Which countries in Latin America are leading AST market growth?
Major markets in Latin America include Brazil, Mexico, and Argentina, where healthcare infrastructure investment and antimicrobial resistance awareness are highest.
RESEARCH METHODOLOGY
In that respect, the research has heavily employed both primary and secondary sources in order to comprehensively study the forces influential in the industry. This methodology comprised market segmentation analysis, industry trends, major players, competitive landscape, key market dynamics, and strategies of key companies.
Secondary Research
The secondary research involves D&B Hoovers, Bloomberg Businessweek, Factiva, white papers, annual reports, company filings, investor presentations, and SEC filings for conducting secondary research in developing a database on major industry participants. Key data with regard to leading players, market segmentation, at a various level, industry trends by segments, significant mergers and acquisitions, and the impact of trends and technological perspectives related to the antimicrobial susceptibility testing market.
Primary Research
Primary research in the report included interviewing a cross-section, both from the demand and supply sides, to capture information qualitatively and quantitatively. Supply side: High-level executives' interviews, such as CEOs, VPs, marketing and sales directors, regional sales managers, and technology and innovation directors were contacted from leading companies and organizations in product therapy markets. On the demand side, research was carried out by discussing with professionals like clinicians, procurement managers, purchase managers, department heads, and experts from hospitals, diagnostic centers, pharmaceutical and biotechnological firms, and research and academic institutes. This was necessary to gain a proper view of the market segmentation, significant players in the market, and key trends and dynamics related to the growth of the market.
A breakdown of the primary respondents is provided below:
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
This research examines the Antimicrobial Susceptibility testing market and revenue share among the market leaders. It made use of a combination of primary and secondary research methods to do so. Primary research involved in-depth interviews with CEOs, directors, and senior marketing executives. Secondary research formed annual and financial reports by major industry players. The market value was determined while following a segment-based strategy, and it used revenue details of leading solution providers for differentiating between sources and services.
Covered segments:
Identify the major companies involved in the world Antimicrobial Susceptibility testing market and document their annual revenues or revenues from their particular product category/business division.
The revenue mapping of these leading competitors, based on 2024 data, captures a good share of the market and is thus extrapolated to estimate the total global value of the Antimicrobial Susceptibility testing market:
Data Triangulation
Based on the methodology, categorical and sub-categories segmentation of the global antimicrobial susceptibility testing market was performed. Further, data triangulation and the segmentation process were undertaken to arrive at an accurate data of different segments for the market. Various analyses involved factors and trends of the demand and supply sides. The integration of detailed top-down and bottom-up approaches offered a holistic overview of the antimicrobial susceptibility testing market
Market Definition
The Antimicrobial Susceptibility Testing market involves the diagnosis and determination of effectiveness against pathogens such as bacteria, fungi, and viruses using antimicrobial agents. It consists of several technologies and methodologies employed for the diagnosis of the susceptibility of microorganisms to a variety of antimicrobial agents through automated systems, molecular diagnostics, and traditional culture-based methods. The main aim of AST is to be able to choose appropriate therapy, enhance patient outcomes, and take against the threat of emerging antimicrobial resistance. The market includes products and services used by clinical laboratories, hospitals, research institutions, and other healthcare facilities.
Stakeholders
- Healthcare institutions (hospitals and clinics)
- Healthcare institutions (hospitals and diagnostic centers)
- Research institutions
- Clinical research organizations
- Academic medical centers and universities
- Reference laboratories
- Accountable Care Organizations (ACOs)
- Research and consulting firms
- Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
- Academic medical centers and universities
- Market research and consulting firms
- Group Purchasing Organizations (GPOs)
- Medical Research Laboratories
- Academic Medical Centers and Universities
Report Objectives
- Define, describe, and project the antimicrobial susceptibility testing (AST) market across various dimensions, including product, type, methods, applications, end users, and regional areas.
- Explore opportunities for stakeholders and provide a detailed analysis of the competitive landscape, highlighting the key players in the market.
- Offer comprehensive insights into the principal factors influencing market growth.
- Analyze micro markets by evaluating individual growth trends, potential, and their contributions to the overall market.
- Monitor and review competitive developments such as new product launches, approvals, agreements, partnerships, expansions, acquisitions, and collaborations in the AST sector.
Get the Full Antimicrobial Susceptibility Testing Market Report
Full forecast, segment splits, and company analysis for all Antimicrobial Susceptibility Testing Market.
- Canada Antimicrobial Susceptibility Testing Market
- US Antimicrobial Susceptibility Testing Market
- Germany Antimicrobial Susceptibility Testing Market
- France Antimicrobial Susceptibility Testing Market
- UK Antimicrobial Susceptibility Testing Market
- Italy Antimicrobial Susceptibility Testing Market
- Spain Antimicrobial Susceptibility Testing Market
- Japan Antimicrobial Susceptibility Testing Market
- China Antimicrobial Susceptibility Testing Market
- India Antimicrobial Susceptibility Testing Market
- Australia Antimicrobial Susceptibility Testing Market
- South Korea Antimicrobial Susceptibility Testing Market
- Brazil Antimicrobial Susceptibility Testing Market
- Mexico Antimicrobial Susceptibility Testing Market
- Rest Of Europe Antimicrobial Susceptibility Testing Market
- Rest Of Asia Pacific Antimicrobial Susceptibility Testing Market
- Rest Of Latin America Antimicrobial Susceptibility Testing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
